Infectious colitis

Summary

Infectious colitis (MONDO:0006039) is a disease and 2 clinical trials. A subtype of colitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	infectious colitis
Mondo ID	MONDO:0006039
EFO	EFO:1000035
NCIT	C78359
SNOMED CT	39341005
UMLS	C0277524
MedGen	75798
Is cancer (heuristic)	no

Also known as: infectious colitis

Disease family

This is a subtype of colitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › intestinal disorder › gastroenteritis › colitis › infectious colitis

Related subtypes (8): ischemic colitis, microscopic colitis, chemical colitis, diversion colitis, ulcerative colitis, ileocolitis, indeterminate colitis, proctocolitis

Subtypes (1): Clostridium difficile colitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE4	1
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT02246361	PHASE4	COMPLETED	Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication
NCT02497417	Not specified	COMPLETED	A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients